The biotech drug developer posted revenue of $24.4 million in the period, which also missed Street forecasts. Five analysts surveyed by Zacks ...
News
- FibroGen: 1Q Earnings Snapshot
- CRISPR tool test approved by FDA
Sherlock Biosciences said the kit works by using a CRISPR-engineered molecule to detect the genetic signature of the SARS-CoV-2 virus. When the ...
- Pandemic prompts increased push to recruit bioscience talent in SA
The San Antonio Economic Development Foundation's Romanita Matta-Barrera said stakeholders need to address skills gaps to grow city's bioscience ...
- Bio-Rad: 1Q Earnings Snapshot
The maker of instruments used in biomedical research posted revenue of $571.6 million in the period. Bio-Rad shares have increased 22% since the ...
- Twist Bioscience: Fiscal 2Q Earnings Snapshot
(AP) _ Twist Bioscience Corp. (TWST) on Thursday reported a loss of $31.8 million in its fiscal second quarter. The South San Francisco, California- ...